Welcome to our dedicated page for Allegheny Tech news (Ticker: ATI), a resource for investors and traders seeking the latest updates and insights on Allegheny Tech stock.
ATI Inc. reports developments tied to its high-performance materials and specialty metal solutions business, with recurring emphasis on aerospace and defense demand, specialty energy applications, margin performance, cash flow, and segment execution. The company serves end markets that also include electronics and medical applications, supported by proprietary process technologies and customer-specific materials capabilities.
ATI news commonly includes quarterly and annual results, earnings webcasts, guidance updates, restructuring or transformation costs, capital allocation actions such as share repurchase authorizations, and leadership or board governance changes. Coverage also reflects the company's operating focus on High-Performance Materials and Components and Advanced Alloys and Solutions.
ATI (NYSE: ATI) priced a public offering of $450 million aggregate principal amount of 5.875% Senior Notes due 2033. The notes pay interest semi-annually and mature on June 15, 2033, unless earlier redeemed.
ATI plans to use about $350 million of net proceeds to redeem all outstanding 5.875% Senior Notes due 2027, with any remaining proceeds for general corporate purposes. Goldman Sachs & Co. and J.P. Morgan are joint book-running managers and co-global coordinators.
ATI (NYSE: ATI) plans to offer a new series of seven-year senior notes, subject to market conditions. Net proceeds are intended to redeem all outstanding 5.875% Senior Notes due 2027, with any remaining funds for general corporate purposes.
Goldman Sachs and J.P. Morgan are joint book-running managers, and the offering uses an effective shelf registration.
ATI (NYSE: ATI) announced that Board Chair, President and CEO Kimberly A. Fields will speak at the Bernstein 42nd Annual Strategic Decisions Conference on May 28, 2026 at 3:30 p.m. ET.
The fireside chat will be live webcast, with an audio replay and full transcript available afterward via ATI's investor relations site.
ATI (NYSE: ATI) announced that CEO Kimberly A. Fields has become Board Chair following the 2026 Annual Meeting, a move first announced in November 2025. Her appointment follows the retirement of former Chair Robert S. Wetherbee and director J. Brett Harvey.
Leroy M. Ball was named Lead Independent Director, reflecting ATI's focus on independent Board oversight and corporate governance. Fields has served as CEO since July 1, 2024 and as a director since February 2024.
ATI (NYSE: ATI) reported Q1 2026 results: sales $1.15B, GAAP net income attributable to ATI $118.2M (EPS $0.85), and adjusted EPS $1.00. Adjusted EBITDA was $231.7M (20.1% of sales), up 310 bps year-over-year. Operating cash flow improved by about $221M. The company raised full‑year adjusted EBITDA, EPS, and adjusted free cash flow guidance and announced an additional $500M share repurchase authorization.
ATI (NYSE: ATI) will webcast its First Quarter 2026 earnings conference call on Thursday, April 30, 2026 at 7:30 a.m. CT (8:30 a.m. ET). First Quarter 2026 results will be published prior to the call at 6:30 a.m. CT (7:30 a.m. ET).
The live broadcast, presentation slides and replay will be available at ATImaterials.com under the "Conference Call" section.
ATI (NYSE: ATI) announced that its Board authorized an additional $500 million share repurchase program on Feb 19, 2026, expected to support a multi-year buyback when combined with the remaining $120 million from the prior authorization.
Repurchases may occur in the open market or via private transactions, will follow SEC Rule 10b-18 pricing and volume limits, and may be modified, suspended, or terminated at the Board's discretion.
ATI (NYSE: ATI) reported Q4 2025 sales of $1.18 billion and net income attributable to ATI of $96.6 million ($0.69 per share). Fiscal 2025 sales were $4.59 billion, with net income of $404.3 million ($2.85 per share) and operating cash flow of $614 million.
Q4 adjusted EBITDA was $231.9 million (19.7% of sales). Management provided FY2026 guidance including adjusted EBITDA of $975M–$1,025M and adjusted EPS of $3.99–$4.27.
Oncolytics Biotech (Nasdaq: ONCY) reported voting results from its Special Meeting of Shareholders held January 15, 2026. All three resolutions passed: the Continuance (move from Alberta to British Columbia) with 14,994,075 votes for (85.21%); the Domestication (move from British Columbia to Nevada, USA) with 15,304,574 votes for (86.98%); and the 2026 Incentive Award Plan with 13,508,657 votes for (76.77%) and 4,087,822 votes against (23.23%).
The 2026 Incentive Award Plan is conditional on completion of the Continuance and Domestication. The company expects to consummate the Continuance and Domestication and for the incentive plan to become effective at the end of the first quarter of 2026.
ATI (NYSE: ATI) scheduled a live webcast for its Fourth Quarter and Full Year 2025 earnings conference call on Tuesday, February 3, 2026 at 7:30 a.m. CT (8:30 a.m. ET). Results will be published prior to the call at 6:30 a.m. CT (7:30 a.m. ET). The conference call and presentation slides will be available at ATImaterials.com, with a replay posted on the same site.
ATI is a global producer of high-performance materials serving aerospace, defense, electronics, medical and specialty energy markets.